The use of cement in partial hip replacements has been linked to a risk of death and heart failure in some patients, researchers from the National Patient Safety Agency have warned.
The experts said such occurrences were rare - but that the issue still warrants investigation.
They examined cases of acute patient deterioration associated with hip hemiarthroplasties with the use of cement to help hold the artificial hip joint in place.
Between 2005 and 2012 there were 62 reports of death or severe harm associated with the procedure in the NHS in England and Wales - one event for every 2,900 operations carried out, they found.
Writing in the journal BMJ Open, the researchers said: "There is a need for stronger evidence that weighs the risks and benefits of cement in hip hemiarthroplasty for fractured neck of femur."
A company sold toxic hip implants used in thousands of operations in Britain knowing they were potentially dangerous, The Daily Telegraph reports.
Depuy, a subsidiary of Johnson&Johnson, continued to market 'metal on metal' hip implants for "at least three years" after a leading British surgeon warned in emails to an executive of the manufacturer that patients were suffering, the newspaper reports.
An American court case has also revealed that the company’s own data also allegedly disclosed that a relatively high proportion of the artificial hips, which are supposed to last a lifetime, were failing after two and a half years.
A joint investigation by the newspaper and the British Medical Journal found that regulators in Slovakia and the Czech Republic were willing to approve devices with similar properties to products that have left patients in "severe pain".
The newspaper reports that the regulation system for medical implants is pan-European and is susceptible to corrupt practices because of competition between rival regulators.
It also claims to have secretly recorded regulators describing licensed products as "horrible" and admitting they are "on the side of the manufacturer" rather than the patient.